CDC Adds 16 Destinations to ‘Very High’ COVID-19 Travel Risk List

Wire Service
By Wire Service
August 3, 2021US News
share
CDC Adds 16 Destinations to ‘Very High’ COVID-19 Travel Risk List
Tourists visit the Ancient Acropolis archeological site in Athens, Greece, on July 1, 2021. (Louisa Gouliamaki/X07402/AFP via Getty Images)

The Centers for Disease Control and Prevention (CDC) added 16 destinations to its “very high” COVID-19 risk level on Monday, including Greece, Ireland, and the U.S. Virgin Islands.

According to the CDC, a risk designation of “Level 4: COVID-19 Very High” means people should avoid travel to these locations. Those who must travel should be fully vaccinated first.

In its overarching guidance, the CDC recommends against all international travel until you are fully vaccinated.

Destinations that fall into the “very high” risk category have had more than 500 cases per 100,000 residents in the past 28 days, according to CDC parameters.

Direct travel of noncitizens from Ireland and Greece to the United States has been suspended since Jan. 25, 2021, under an executive order limiting travel from multiple countries. The White House recently said those restrictions would remain in place amid surging cases from the Delta variant.

The following 16 destinations moved to the CDC’s “Level 4: COVID-19 Very High” category on Aug. 2:

—Andorra
—Curaçao
—Gibraltar
—Greece
—Guadeloupe
—Iran
—Ireland
—Isle of Man
—Kazakhstan
—Lesotho
—Libya
—Malta
—Martinique
—Saint Barthelemy
—Saint Martin
—U.S. Virgin Islands.

Here are some other typically popular travel destinations on the Level 4 category (as of Aug. 3):

—Brazil
—Colombia
—Costa Rica
—Maldives
—The Netherlands
—Panama
—Portugal
—Seychelles
—Spain
—United Arab Emirates
—United Kingdom

You can look up the CDC’s risk level of any destination on its travel recommendations page.

The CNN Wire contributed to this report

ntd newsletter icon
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
By registering for the newsletter, you agree to the Privacy Policy.
Comments